Related by context. All words. (Click for frequent words.) 80 Improves Survival 80 Initiates Clinical Trial 80 FDA Okays 79 Completes Patient Enrollment 79 Demonstrates Significant 79 Receives Orphan Drug Designation 79 Prolongs Survival 78 Drug Candidate 78 Study Demonstrates 78 Meets Primary Endpoint 78 Improves Outcomes 78 Presents Preclinical Data 78 Significantly Improves 78 Initiates Clinical 77 Shows Promise Against 77 Present Preclinical Data 77 Initiate Clinical Trial 77 Anti Tumor 76 Announces FDA Clearance 76 Demonstrates Positive 76 FDA Clears 76 Files IND 76 Orally Active 76 Patients Treated With 76 Gets FDA Clearance 76 Shows Promising 76 Drug Shows Promise 76 Submits NDA 75 Initiates Phase II 75 Shows Efficacy 75 Initiates Enrollment 75 Study Evaluating 75 Shows Promise 75 Hsp# Inhibitor 75 Licenses Novel 75 Advanced Melanoma 75 Granted Orphan Drug 75 Preclinical Data 75 Reduces Risk 75 Novel Oral 75 Phase 2b Clinical Trial 75 Kinase Inhibitor 75 FDA Approvals 75 Clinical Trial Results 75 Adjuvant Treatment 75 Tyrosine Kinase Inhibitor 74 Initiates Dosing 74 Teva Provides Update 74 Hematological Malignancies 74 Hormone Refractory Prostate Cancer 74 Achieves Primary Endpoint 74 Test Detects 74 Investigational Compound 74 Proven Effective 74 Transdermal Patch 74 Completes Enrollment 74 Phase 2b Trial 74 Single Dose 74 Newly Diagnosed Multiple Myeloma 74 Improve Survival 74 Successfully Completes Phase 74 Previously Treated 74 Significantly Improved 74 Significantly Reduces 74 IND Application 74 Antitumor Activity 74 Previously Untreated 74 Demonstrates Efficacy 74 Develop Novel 74 Patients Receiving 74 Tumor Targeting 74 Improves Quality 74 Receives Orphan Drug 73 Data Suggest 73 Protease Inhibitors 73 Phase 2a Trial 73 Lung Cancer Drug 73 Initiates Clinical Trials 73 Proves Effective 73 Presents Positive 73 Clinical Trial Evaluating 73 Node Positive 73 Phase III Trial 73 FDA Accepts 73 Treatment Reduces 73 Immunomedics Announces 73 Patients Treated 73 Interferon Alpha 73 Drug Fails 73 Further Validates 73 Study Shows Benefits 73 Initiates Phase III 73 Combo Therapy 73 Inhibits 73 Survival Benefit 73 Anti Tumor Activity 73 Secondary Hyperparathyroidism 73 Files Patent Application 73 Disease Modifying 73 Small Molecule 73 JAK2 Inhibitor 73 Novel Therapeutic 73 Phase IIb Clinical Trial 73 Mouse Model 73 Phase III Clinical Trial 73 Demonstrated Significant 72 Phase IIb Trial 72 Reports Preclinical Data 72 Shows Statistically Significant 72 Phase IIa Clinical Trial 72 Levels Linked 72 Systemic Delivery 72 Diabetic Foot Ulcer 72 Non Invasive Treatment 72 Study Indicates 72 Lupus Drug 72 Significantly Reduced 72 Investigational Treatment 72 Showed Significant 72 Vaccine Adjuvant 72 RNAi Therapeutic 72 HER2 Positive Breast Cancer 72 Recombinant Human 72 Effectively Treats 72 Gene Linked 72 Protein Linked 72 Therapy Reduces 72 Oral Calcitonin 72 Cholesterol Lowering Drug 72 Lowers Risk 72 Fungal Infections 72 Inhaled Corticosteroids 72 Reduced Risk 72 Receives Patent 72 Novel Compound 72 Severe Sepsis 72 Therapeutic Efficacy 72 Proves Successful 72 Renal Cell Carcinoma 72 Receives FDA Clearance 72 Significantly Increases 72 Osteoporosis Treatment 72 Transdermal Delivery 72 Predict Response 72 Trial Evaluating 72 Commercializes 72 Humanized Anti 72 Pivotal Study 72 Is Well Tolerated 72 Therapy Improves 72 FDA Approves Drug 72 Appears Safe 72 Protease Inhibitor 72 PRN FDA Approves 72 Metabolic Disorder 72 Myocardial Perfusion Imaging 71 Demonstrates Statistically Significant 71 Receives Approvable Letter 71 Announce License Agreement 71 JAK Inhibitor 71 Demonstrates Potent 71 Dramatically Increases 71 Atypical Antipsychotic 71 Oral Spray 71 Receives Milestone Payment 71 Sign Licensing Agreement 71 Slow Progression 71 Achieves Milestone 71 Submits Biologics License Application 71 Low Dose 71 novel emulsion formulation 71 Rheumatoid Arthritis Patients 71 Novel Inhibitor 71 HER2 Positive 71 Advanced Colorectal Cancer 71 Prostate Cancer Patients 71 Collaborators Present 71 Anti Inflammatory 71 Treatment Naïve 71 Treating Chronic 71 Psoriasis Drug 71 Clinical Outcome 71 Combination Therapy 71 BioSante Pharmaceuticals Announces 71 Guidelines Issued 71 Molecular Diagnostic Test 71 Adjuvant Therapy 71 Kidney Function 71 Novel Treatments 71 Combination Treatment 71 Sign License Agreement 71 Well Tolerated 71 Presents Preclinical 71 Initiate Phase 71 Diabetic Neuropathy 71 Initiates Phase 71 Spectrum Pharmaceuticals Announces 71 NDA Submission 71 Cites Positive 71 Completes Dosing 71 Files Investigational 71 Anticancer Drug 71 FDA Approves 71 Statistically Significant 71 Receive Milestone Payment 71 Commonly Used 71 Investigational Agent 71 MEK Inhibitor 71 Antigen Specific 71 Patent Covering 71 Genes Linked 71 Arthritis Drug 71 Initiate Phase III 71 Treatment Regimen 71 AnaSpec Introduces 71 Diagnostic Tests 71 Anti Angiogenic 71 Receives Positive Opinion 71 Rheumatoid Arthritis Drug 71 Osteoporosis Drug 71 Submits IND 71 Bosutinib 71 R lenalidomide 70 Beneficial Effects 70 Assay Kits 70 SPRYCEL ® 70 Could Revolutionize 70 Aurora Kinase 70 Conjugate 70 Presents Positive Preclinical 70 Improved Survival 70 Adjunctive Therapy 70 HDAC Inhibitor 70 Shown Effective 70 Begins Shipment 70 Generic Versions 70 Being Studied 70 Oral Fingolimod 70 Commences Phase 70 Preclinical Study 70 Investigational Oral 70 Holds Promise 70 Induces 70 Long Term Efficacy 70 Patient Enrollment 70 Plaque Psoriasis 70 Begins Dosing 70 Launches Generic Version 70 Antibody Drug Conjugate 70 Reduces Pain 70 Prostate Cancer Vaccine 70 Brain Metastases 70 Viral Load 70 Clinical Efficacy 70 Dose Escalation 70 Advanced Prostate Cancer 70 Antiangiogenic 70 Commercialize 70 Clinical Study Shows 70 Medoxomil 70 Tumor Response 70 Monoclonal Antibody 70 Oral Formulation 70 accumulate preferentially 70 Demonstrates Sustained 70 platform HDL Mimetic 70 Vaginal Gel 70 Targeted Therapies 70 Prostate Cancer Treatment 70 Slows Progression 70 Immunotherapeutic 70 Therapeutic Potential 70 Chemotherapeutic Agents 70 Immunomodulatory 70 Lung Cancer Survival 70 Awarded Patent 70 Receives Fast Track 70 Flamel Technologies Announces 70 Therapeutic Antibody 70 Announces Initiation 70 Prolongs Life 70 Novel Mechanism 70 Hypertensive Patients 70 Mimetics 70 HCV Protease Inhibitor 70 Oral Mucositis 70 Relapsed Refractory 70 Unfractionated Heparin 70 Blood Pressure Drug 70 Reduces Mortality 70 Collaborators Publish 70 Contrast Agent 70 Enrolls First 70 Hormone Receptor Positive 70 Announces Tentative Approval 70 Disease Progression 70 Immune Cells 70 Epilepsy Drug 70 Chemotherapeutic 70 IMiDs ® 70 Antitumor 70 Modulates 70 Introduces Breakthrough 70 Study Reinforces 70 Announce Collaboration Agreement 70 Suppresses 70 Combination REOLYSIN R 70 Bone Metastases 70 Pooled Analysis 70 Predict Risk 70 Phase 1b Clinical Trial 70 Submits Supplemental 70 Kinase Inhibitors 70 Elderly Patients 70 Submits Application 69 Gene Variant 69 Effective Than 69 Treatment Shows Promise 69 Receives CE Marking 69 Therapeutic Vaccines 69 Lymphoid 69 Patent Issued 69 Flagship Product 69 Increases Risk 69 Helps Predict 69 Schizophrenia Treatment 69 Pharmacokinetic Study 69 Breast Cancer Recurrence 69 ORLive Presents 69 Soft Tissue Sarcoma 69 Smooth Muscle 69 Therapy Shows Promise 69 Lung Cancer Patients 69 Differentiates 69 Protein Synthesis 69 Treatment Experienced 69 Provides Comprehensive 69 Demonstrate Significant 69 candidates Azedra TM 69 Multiple Myeloma Patients 69 Adjuvant Chemotherapy 69 Tumor Cell 69 Preclinical Models 69 Nicotine Vaccine 69 Plus Ribavirin 69 Fast Track Status 69 Lupus Nephritis 69 Drug Resistant 69 Patients Undergoing 69 Earns Milestone Payment 69 Beta Blocker 69 Peginterferon 69 Announce Merger Agreement 69 Chemoradiation 69 Vildagliptin 69 Inhaled Nitric Oxide 69 Therapeutic Competitors Companies 69 Anthracycline 69 Milestone Payment 69 Anticancer Drugs 69 Renal Cell Cancer 69 Announces Discontinuation 69 Submits Response 69 Atopic Dermatitis 69 See CLINICAL PHARMACOLOGY 69 Randomized Trials 69 FOR FURTHER INFORMATION ABOUT 69 Study Proves 69 Receptor Agonist 69 Pivotal Phase III 69 Drug Combo 69 Announces Poster Presentations 69 Contrast Agents 69 Impairs 69 Smoking Linked 69 Study Confirms 69 Pegylated 69 Discontinues 69 Chemotherapy Improves 69 Metastatic Melanoma 69 Cancer Cells 69 Genes Predict 69 RNAi Therapeutics 69 Dose Escalation Study 69 Antidepressants Linked 69 5 FU leucovorin 69 Pediatric Patients 69 Renal Cancer 69 FDA Approves Generic 69 Ovarian Cancer Patients 69 Myelodysplastic Syndromes 69 Extended Release 69 Study Shows Significant 69 Respiratory Virus 69 Phase 2b Study 69 Progenitor Cells 69 Genes Involved 69 Successfully Treats 69 Mouse Models 69 Allogeneic 69 Mg Uk 69 Breast Cancer Cells 69 Testosterone Patch 69 Synthetic Peptide 69 Investigational Drug 69 Interferon Beta 69 Less Invasive 69 Emerging Therapies 69 Urine Test 69 Boosts Survival 69 Study Showed 69 pralatrexate injection folate analogue 69 Hepatitis C Genotype 69 Gene Mutation 69 Granulocyte Colony Stimulating Factor 69 Immunosuppressant 69 Expand Collaboration 69 Asthma Treatment 69 Phase 2a Clinical Trial 69 Topical Treatment 69 Imaging Technique 69 Alfacell proprietary ribonuclease 69 AVI BioPharma Announces 69 Aptamer 69 Xeloda ® 69 Announce Licensing Agreement 69 Controlled Trial 69 Inflammatory Markers 69 Polymerase Inhibitor 69 Announces Presentation 69 Prove Effective 68 Genes Identified 68 Zicam Cold Remedy RapidMelts 68 Nucleoside 68 Posaconazole 68 Immune Responses 68 Anti Angiogenesis 68 Expanded Indication 68 Treat Anemia 68 Gout Drug 68 Announces Publication 68 Hormonal Therapy 68 Clinical Validation 68 Helps Prevent 68 Efficacy Trial 68 Demonstrates Improved 68 Treatment Naive 68 Significantly Improve 68 Mg Usa 68 Protects Against 68 Attenuates 68 Metastatic Prostate Cancer 68 Rotavirus Vaccine 68 Confirms Efficacy 68 Help Predict 68 Tyrosine Kinase Inhibitors 68 Novel Compounds 68 Vascular Inflammation 68 Analytical Tool 68 Albuferon TM 68 Novel Antibiotic 68 Phase III Trials 68 Fixed Dose 68 Fewer Side Effects 68 Demonstrates Ability 68 Biomarker Study 68 Hemodialysis Patients 68 Circulating Tumor Cells 68 Mylan Receives Approval 68 topical gel formulation 68 Lowers Blood Pressure 68 Chronic Hepatitis B 68 Study Compares 68 Hepatitis C Treatment 68 Subtypes 68 Lung Cancer Treatment 68 Contaminant Found 68 Gene Variants 68 Bazedoxifene 68 Antiarrhythmic 68 Randomized Double Blind 68 Strongly Linked 68 TNF Blockers 68 Skeletal Muscle 68 oncolytic virus therapies 68 TO AVOID PREGNANCY WHILE 68 Study Casts Doubt 68 Unresectable 68 Helps Identify 68 Genetic Predisposition 68 Generic Version 68 Gene Variation 68 Vertebral Fractures 68 Xcytrin R 68 Expands Availability 68 Hospital Acquired Pneumonia 68 Fondaparinux 68 Crofelemer budesonide foam 68 Chronic Hepatitis C 68 Relapsing Multiple Sclerosis 68 Virus Infection 68 Advanced Pancreatic Cancer 68 Cancer Treatments 68 Commercially Available 68 Bucindolol 68 Prospective Randomized 68 Postmenopausal Osteoporosis 68 Complicated Skin 68 Vaccine Shows Promise 68 Breast Cancer Patients 68 Pharmaceuticals Initiates 68 Delivers Next Generation 68 Introduces Novel 68 Pivotal Trial 68 Begin Clinical Trials 68 Treated Patients 68 Patents Covering 68 Pre Cancerous 68 Fixed Dose Combination 68 Successfully Treated 68 Announce Collaboration 68 Signaling Pathway 68 Intravitreal 68 Obesity Linked 68 Unveils Revolutionary 68 First Patient Enrolled 68 Cutaneous T 68 Announces Immediate Availability 68 Introduces Revolutionary 68 Seasonal Influenza Vaccine 68 Blood Clotting 68 Gastrointestinal Stromal Tumors 68 Factor Receptor 68 Introduces Enhanced 68 Statin Drugs 68 Successfully Completed 68 Technological Advances 68 Naive Patients 68 IND Filing 68 Helps Diagnose 68 BioElectronics Announces 68 Personalized Immunotherapy 68 Cholesterol Drugs 68 vapreotide acetate 68 Pivotal Phase 68 Refractory Hodgkin Lymphoma 68 Erythropoietic 68 Guidelines Recommend 68 Breast Tumors 68 Taxane 68 Study Examines 68 Epoetin Alfa 68 Could Save Lives 68 Autoimmune Diseases 68 Bronchodilator 68 Kidney Transplant Patients 68 TM Aganocide 68 Help Detect 68 Accelerate Commercialization 68 Myeloma Patients 68 Diet Linked 68 Gastric Cancer 68 Enlarged Prostate 68 Exposure Linked 68 Knee Osteoarthritis 68 Hematological Cancers 68 Develops Novel 68 Novel Anti Inflammatory 68 FDA Warns Against 68 Results Confirm 68 Anticancer Activity 68 Aeolus Pharmaceuticals Announces 68 Migraine Drug 68 Cocaine Addiction 68 Initiates Phase 2b 68 FDA APPROVES 68 Advanced Renal Cell 68 Breast Cancer Treatment 68 Metastatic Colorectal Cancer 68 Safinamide 68 Glucose Control 68 Benign Prostatic Hyperplasia 68 Drug Prevents 68 Phase IIa Trial 68 Could Detect 68 Nilotinib 68 BiTE Antibody 68 Amgen Neulasta R 68 Treating Depression 68 Clinical Trial Data 68 Reduce Risk 68 Deliver Powerful 68 CYP#A# CYP#D# 68 siRNA Delivery 68 Announces License Agreement 68 Companion Diagnostic 67 LifeVantage Announces 67 Spinal Fusion 67 Introduces Next Generation 67 Study Validates 67 Vascular Grafts 67 Obtains Exclusive License 67 Platform Enables 67 AFREZZA TM 67 Begins Shipping 67 Cholesterol Lowering 67 Antithrombin 67 Could Predict 67 Anti CD# Antibody 67 Receives SFDA Approval 67 Bioresorbable 67 Introduces Unique 67 Randomized Phase 67 Lung Cancer Trial 67 Vaccine Candidate 67 Interferon Gamma 67 Antiviral Activity 67 Migraine Treatment 67 Receives ISO #:# [002] 67 Genetic Tests 67 Achieves Positive 67 Receives Marketing Authorization 67 Confirmatory Phase 67 CYP#A# substrate 67 Neoadjuvant Chemotherapy 67 First Patient Dosed 67 FDA Clearance 67 ® bortezomib 67 Efficacious 67 Study Identifies 67 Provides Update Regarding 67 Castration Resistant Prostate Cancer 67 Recurrent Breast Cancer 67 Receives Tentative Approval 67 Pharmacokinetics PK 67 Reveals Significant 67 Human Neural Stem 67 Vaccine Protects Against 67 Could Prevent 67 Antifungal 67 Dramatically Improves 67 Antidepressant Drug 67 Treatment Resistant 67 Sipuleucel T 67 Fludara ® 67 TB Vaccine 67 Reveals Positive 67 Skin Lesions 67 Biocompatibility 67 Prophylactic Treatment 67 Unveils Next Generation 67 Potent Inhibitor 67 External Beam 67 Tezampanel 67 Peginterferon alfa 2b 67 tenofovir disoproxil fumarate Viread 67 Entry Inhibitor 67 Regenerative Cells 67 Strengthens Balance Sheet 67 Risk Stratification 67 Newly Diagnosed 67 Prodrug 67 Integrase Inhibitor 67 candidates Azedra 67 Pruvel TM 67 Protein Involved 67 Hedgehog Pathway 67 targeted antifolate 67 Unveils Groundbreaking 67 Tumor Growth 67 Pivotal Clinical Trial 67 Blood Thinning 67 Epidermal Growth Factor Receptor 67 Anticancer Agent 67 Poorly Controlled 67 VIVUS Announces 67 Insulin Resistance 67 Nanoemulsion 67 Levoleucovorin 67 Significant Improvement 67 MOVIPREP R 67 Sangamo BioSciences Announces 67 Develops Breakthrough 67 Epoetin 67 Phase III Pivotal Trial 67 Monotherapy 67 Protein Expression 67 substantially excreted 67 Anthrax Toxin 67 Anemia Drug 67 Patients Suffering 67 Diagnostic Criteria 67 Tumor Necrosis Factor 67 Regains NASDAQ 67 Transdermal Drug 67 Ultrasensitive 67 Receptor Antagonist 67 Testosterone Gel 67 Dramatically Reduce 67 Decitabine 67 Sevelamer 67 Endometrial Cancer 67 Supplemental Biologics License Application 67 Localized Prostate Cancer 67 Hepatocellular Carcinoma 67 Protein Biomarkers 67 Genentech Provides Update 67 Calcium Supplements 67 Overactive Bladder 67 Preterm Labor 67 Cell Transplants 67 Transplant Patients 67 Eases Pain 67 Widely Used 67 Paraplatin ® 67 Prolongs 67 Identifies Potential 67 Unveils Expanded 67 Premenopausal Women 67 Platinol ® cisplatin 67 Blood Thinner 67 Chemotherapy Induced Anemia 67 Inflammatory Disease 67 Receives Favorable 67 Clinically Proven 67 Coronary Arteries 67 ATRA IV 67 IMiDs ® compound 67 Genotyping Test 67 Signaling Pathways 67 Report Analyzes 67 Melphalan 67 Vitrasert R 67 Pegloticase 67 Doripenem 67 Darbepoetin Alfa 67 Can Predict 67 Artery Disease 67 Scientists Identify 67 Results Indicate 67 ® lenalidomide 67 Receives Complete Response 67 Cardiotoxicity 67 Pegylated Liposomal Doxorubicin 67 Capecitabine 67 Mesothelioma Treatment 67 Chronic Lymphocytic Leukemia 67 Osteoporosis Drugs 67 Versus Placebo 67 Autoimmune Disease 67 Inhalation Solution 67 Telaprevir VX 67 Telik logo TELINTRA 67 Stakeholder Opinions 67 Hypercholesterolemia 67 Non Inferiority 67 Study Evaluates 67 Diabetic Patients 67 AAG geldanamycin analog 67 CDC Recommends 67 Helps Relieve 67 II Clinical Trial 67 Breast Density 67 hyaluronidase enzyme 67 DNA Methylation 67 lead molecular radiotherapeutic 67 Pertuzumab 67 Interferon Alfa 67 investigational oral inhibitor 67 Angiogenic 67 Antiplatelet 67 Potentially Fatal 67 Taro Receives 67 Lowers Cholesterol 67 Muscle Wasting 67 Lung Cancers 67 Resistant Hypertension 67 Gene Mutations 67 Provides Guidance 67 Develop Next Generation 67 Glatiramer Acetate 67 Provides Unprecedented 66 Clostridium difficile Infection 66 Danazol 66 Adipose Derived Stem Cells 66 Intra Arterial 66 Minimally Invasive Treatment 66 Novel Protein 66 LymphoStat B TM 66 Progressive Multifocal Leukoencephalopathy 66 Tablet Formulation 66 Hepatic Encephalopathy 66 Antiviral Drugs 66 Orally administered 66 NASH Huntington 66 Effective Treatments 66 Poster Presentations 66 Phase III Clinical Trials 66 Commonly Prescribed 66 Antimicrobial Coating 66 Tumor Cells 66 INSPIRE Trial Phase III 66 Outperforms 66 refractory chronic lymphocytic 66 STERIS Corporation Announces 66 Treatment Naive Patients 66 Estrogen Receptor 66 Atypical Antipsychotics 66 Targeted Therapy 66 Relapsed Multiple Myeloma 66 Obese Patients 66 Therapeutic Vaccine 66 Introduces Powerful 66 NICE Recommends 66 Serious Infections 66 Announce Commencement 66 COPEGUS R 66 Study Pinpoints 66 Respiratory Distress 66 Erectile Dysfunction Drug 66 Desvenlafaxine Succinate 66 Recurrent Prostate Cancer 66 Hepatocellular 66 Allergic Rhinitis 66 Injectable Drug 66 ® decitabine 66 Skin Resurfacing 66 Aztreonam Lysine 66 Heart Failure Patients 66 Protein Biomarker 66 C1 Inhibitor 66 Issued Patent 66 Replacement Therapy 66 Helps Determine 66 Pegylated Interferon 66 Announce Breakthrough 66 Androgen Independent 66 Delivers Unprecedented 66 Chemotherapy Induced 66 Telik Announces 66 Laryngeal Cancer 66 Interferon beta 1a 66 Chemotherapy Regimen 66 Acute Heart Failure 66 Double Blind Placebo 66 HuMax 66 Post Menopausal 66 R bisoprolol Euthyrox 66 Adult Stem Cell Therapy 66 Acute Ischemic Stroke 66 Stem Cell Treatment 66 Awarded Patents 66 Can Detect 66 Lung Cancer Vaccine 66 Oral Mist 66 humanized therapeutic 66 Lyophilized 66 Schizophrenia Drug 66 Reports Positive 66 Malignant Glioma 66 Celebrates Successful 66 Angiotensin Converting Enzyme 66 Osteoarthritis Patients 66 Pralatrexate 66 Neuroendocrine Tumors 66 Bladder Cancer 66 ARRY # 66 Subsidiary Enters 66 Study Shows Promise 66 Heart Transplant Recipients 66 Osteoarthritis Pain 66 ISSI Announces 66 Ixabepilone 66 Parathyroid Hormone 66 Zorbtive TM 66 Genes Associated 66 COLLABORATION WITH 66 Critically Ill Patients 66 Hepatitis Virus 66 Clinically Tested 66 rxRNA 66 agonistic human 66 oral prodrug 66 Announces Ticker Symbol 66 R memantine HCl 66 Mycophenolate Mofetil 66 Appoints Seasoned 66 Non Invasive 66 Announces Successful Completion 66 Virus Linked 66 Inhaled Insulin 66 Asthma COPD 66 Iron Overload 66 Jointly Announce 66 Carbidopa Levodopa 66 IIa Clinical Trial 66 Sirolimus Eluting Stent 66 HuMax TAC 66 Postmenopausal Women 66 Milestone Payment From 66 Infected Patients 66 brand ciclesonide HFA 66 Sleep Disturbances 66 Trastuzumab DM1 66 Develops Innovative 66 Macrolide 66 non nucleoside inhibitor 66 Helps Reduce 66 Maven Semantic 66 Crit Rev 66 Sapacitabine 66 Hormone Therapy 66 Vaccine Adjuvants 66 Abuse Resistant 66 Thyroid Hormone 66 Broadens Its 66 Tuberculosis Vaccine 66 Commercialize Novel 66 Meta Analysis 66 Liposomal 66 SABESP Announces 66 BioElectronics Corporation Announces 66 Announces Licensing Agreement 66 Oral Laquinimod 66 Onyx Pharmaceuticals Announces 66 Pulmonary Arterial Hypertension 66 Controlled Study 66 Enzo Biochem Reports 66 VANOS TM 66 Salix Pharmaceuticals Announces 66 Cognitive Function 66 topoisomerase II inhibitor 66 Vaccine Prevents 66 Fracture Risk 66 Inflammatory Pain 66 Therapeutic Targets 66 Acquires Exclusive 66 Detect Cancer 66 Dose Ranging 66 Brain Scans 66 Device Helps 66 Maribavir 66 Expands Capabilities 66 dasatinib Sprycel 66 Inhaled Liposomal Ciprofloxacin 66 Cytotoxic 66 Validates 66 Brain Cells 66 PROSTASCINT R 66 Symptom Relief 66 R Saizen R 66 Stent Restenosis 66 Empowers Consumers 66 ALTROPANE R 66 Moderate Drinking 66 Dialysis Patients 66 Endothelial Cells 66 Dry Powder Inhalers 66 Proteasome 66 GRAS Status 66 Generic Version Of 66 Long Lasting 66 Showcases Innovative 66 Shingles Vaccine 66 Fluorouracil 66 Significant Improvements 66 Data Indicate 66 Helps Detect 66 Demystifies 66 PEGylated anti 66 Organ Rejection 66 Researchers Identify 66 EntreMed Presents 66 Skin Disorders 66 Lower Blood Pressure 66 Receives Certification 66 Pivotal Trials 66 Intravesical 66 Unveils Breakthrough 66 Help Diagnose 66 Adjuvanted 66 Magnetic Nanoparticles 66 microRNA Therapeutics 66 Placebo Controlled Trial 66 XPEL Announces 66 lexidronam injection 66 Regenerative Cell 66 DP VPA 66 Antipsychotic Drug 66 interferon gamma 1b 66 Metabolic Endocrinology 66 Commence Phase 66 Veeco Introduces 66 Treatment Naïve Patients 65 Anti TNF 65 Stent Placement 65 SBIR Grant 65 Pramlintide 65 Software Simplifies